9939 — Kintor Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Kintor Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,055	875	456	147	32.7
Net Total Receivables	0.428	0.024	6.5	15.7	7.26
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,526	1,508	473	172	55.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	267	285	222	174	158
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,068	2,055	869	515	341
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	220	318	225	167	128
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	413	560	411	221	158
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Total Equity	1,655	1,495	458	294	183
Total Liabilities & Shareholders' Equity	2,068	2,055	869	515	341
Total Common Shares Outstanding